By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genomic Health said today that it has accelerated development of its prostate cancer test with the goal of launching it in 2013, a year earlier than it had previously estimated.

The firm also said that Israeli insurance firm Clalit has agreed to provide reimbursement for its Oncotype Dx colon cancer test and that it expects to report results from a second recurrence study in stage II colon cancer in 2011.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.